Review of 68Ga-Pentixafor PET/CT Utility in Lung Cancer Diagnosis and Management
Lung Scans Get Smarter With New Imaging Tool
This narrative review examines the utility of 68Ga-Pentixafor PET/CT in patients with lung cancer. The authors synthesize evidence regarding…
You wake up, cough again — just like the past few weeks.
Narrative review summarizes bispecific antibodies and CAR T-cell therapy for advanced lung cancer.
New Lung Cancer Tools Are Coming Soon
This narrative review evaluates bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for patients with advanced non–smal…
Imagine a soldier who can fight two enemies at once.
Phase II studies evaluate tislelizumab plus sitravatinib or anlotinib maintenance in extensive-stage small-cell lung cancer.
Can adding two drugs after chemo help some lung cancer patients survive longer?
These prospective phase II single-arm studies assessed tislelizumab combined with sitravatinib or anlotinib as maintenance therapy in previo…
Adding tislelizumab plus sitravatinib or anlotinib after chemo kept some small-cell lung cancer patients cancer-free for 6.4 to 7.8 months.
Phase I study finds amrubicin-cisplatin with radiotherapy feasible in limited-stage SCLC
Small study tests new drug combination with radiation for limited-stage small cell lung cancer
A Phase I dose-finding trial in 9 treatment-naïve patients with limited-stage small cell lung cancer established amrubicin 25 mg/m² plus cis…
A new drug combination with radiation showed a 100% response rate and 64.8% five-year survival in early-stage small cell lung cancer patient…